UNCY Form 8-K: Press Release Furnished for Q2 Ended June 30, 2025

Rhea-AI Filing Summary

Unicycive Therapeutics reported that it has issued a press release announcing its financial results for the three months ended June 30, 2025 and provided a business update. The company furnished that press release as Exhibit 99.1 to its Form 8-K and clarified the disclosure is being furnished, not filed for purposes of the Exchange Act and will not be incorporated by reference into registration statements, except as expressly stated. The Form 8-K also identifies the company as an emerging growth company.

Insights

Financial Analyst

TL;DR: The filing furnishes Q2 results and a business update but contains no financial figures; investors must review the press release for details.

The Form 8-K notifies the market that a press release covering results for the quarter ended June 30, 2025 has been furnished as Exhibit 99.1. The filing explicitly states the press release is furnished rather than filed, which limits incorporation and liability under Section 18. Because the 8-K itself does not include revenue, earnings, guidance, or balance sheet figures, the filing alone provides limited quantitative insight; material financial details will be found only in the referenced press release.

Corporate Governance Expert

TL;DR: This is a routine Form 8-K furnishing of a press release; the company follows standard disclosure form and notes emerging growth company status.

The document follows standard disclosure practice by furnishing a press release as Exhibit 99.1 and affirming it is not "filed" for Section 18 purposes. The filing also indicates the registrant checked the box identifying itself as an emerging growth company. The Form 8-K does not show any change in officers, material transactions, or governance actions within its text, and contains no financial tables within the filing itself.

false 0001766140 0001766140 2025-08-14 2025-08-14 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 14, 2025

Unicycive Therapeutics, Inc.

(Exact name of registrant as specified in its charter)

Delaware		001-40582		81-3638692
(State or other jurisdiction of		(Commission File Number)		IRS Employer
incorporation or organization)				Identification No.)

4300 El Camino Real, Suite 210

Los Alto, CA 94022

(Address of principal executive offices)

Registrant’s telephone number, including area code: (650) 351-4495

(Former name or former address, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class:		Trading Symbol(s)		Name of each exchange on which registered:
Common Stock		UNCY		Nasdaq Capital Market

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Conditions.

On August 14, 2025, Unicycive Therapeutics, Inc. issued a press release announcing its financial results for the three months ended June 30, 2025 and provided a business update. A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K.

The information disclosed under this Item 2.02, including Exhibit 99.1 hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, except as expressly set forth in such filing.

Item 9.01. Financial Statements and Exhibits

(d) Exhibits.

99.1		Press Release of Unicycive Therapeutics, Inc. dated August 14, 2025.
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

1

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: August 14, 2025

	UNICYCIVE THERAPEUTICS, INC.
	By:	/s/ Shalabh Gupta
		Shalabh Gupta
		Chief Executive Officer

2

FAQ

What did Unicycive (UNCY) disclose in this Form 8-K?

The Form 8-K states that Unicycive furnished a press release announcing its financial results for the three months ended June 30, 2025 and provided a business update; the press release is Exhibit 99.1.

Is the press release in the Form 8-K filed or furnished?

The filing explicitly says the information, including Exhibit 99.1, is being furnished and shall not be deemed 'filed' for purposes of Section 18 of the Exchange Act.

Does the Form 8-K include financial figures for Q2 2025?

No. The Form 8-K notes a press release announcing results was furnished, but the 8-K text does not include financial tables or specific results.

Where can I find the actual financial results mentioned in the filing?

The filing indicates the financial results and business update are contained in the press release furnished as Exhibit 99.1 to the Form 8-K.

Does the Form 8-K indicate any other material transactions or officer changes?

No. The Form 8-K only references the furnished press release and lists exhibits; it does not disclose material transactions or changes in officers within the filing text.